Enterovirus type 71- coxsackievirus type A16, bivalent inactivated vaccine (Human diploid cell)

肠道病毒71型-柯萨奇病毒A16型二价灭活疫苗（人二倍体细胞）

Report date: 2023/09/11 17:47:08

Base Information

Drug NameEnterovirus type 71- coxsackievirus type A16, bivalent inactivated vaccine (Human diploid cell)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Inactivated vaccine > Whole microorganism inactivated vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHand, Foot and Mouth DiseaseCoxsackievirus InfectionsEnterovirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesInstitute Of Medical Biology, Chinese Academy Of Medical Sciences

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesInstitute Of Medical Biology, Chinese Academy Of Medical Sciences

Inactive CompaniesN/A

Active IndicationsHand, Foot and Mouth DiseaseCoxsackievirus InfectionsEnterovirus Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A